FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Getting More Done With Less Blood.

2.

3D virtual staining technology enables non-invasive observation of cancer tissue

3.

According to new studies, some cancer patients can safely forego radiation therapy.

4.

We Don't Always Know What's 'Best' for Our Patients

5.

Study opens up possibility of bespoke prostate cancer treatment


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot